News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Raffaele Colombo: Sacituzumab Tirumotecan Versus Docetaxel in EGFR-Mutated Advanced NSCLC
Raffaele Colombo/LinkedIn
Jun 12, 2025, 10:54

Raffaele Colombo: Sacituzumab Tirumotecan Versus Docetaxel in EGFR-Mutated Advanced NSCLC

Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, posted on X:

“OptiTROP-Lung03 published on The BMJ: sacituzumab tirumotecan (sac-TMT) versus docetaxel for previously treated EGFR-mutated advanced NSCLC.

  • sac-TMT vs docetaxel
  • ORR: 45% vs 16%
  • PFS: 6.9 vs 2.8 months
  • OS: NR, HR=0.49

(data also presented at ASCO25).”

Title: Sacituzumab tirumotecan versus docetaxel for previously treated EGFR-mutated advanced non-small cell lung cancer: multicentre, open label, randomised controlled trial

Authors: Wenfeng Fang, Xingya Li, Qiming Wang, Xiangjiao Meng, Wei Zheng, Longhua Sun, Wenxiu Yao, Wu Zhuang, Yun Fan, Minglei Zhuo, Yongzhong Luo, Zhiye Zhang, Xia Song, Runxiang Yang, Jiacheng Yang, Xiaoping Jin, Yina Diao, Junyou Ge, Li Zhang

Read The Full Article at The BMJ.

Raffaele Colombo: Sacituzumab Tirumotecan Versus Docetaxel in EGFR-Mutated Advanced NSCLC

More posts featuring Raffaele Colombo.

ASCO25 cancer Jiacheng Yang Junyou Ge Li Zhang Longhua Sun Minglei Zhuo NSCLC OncoDaily Oncology Qiming Wang Raffaele Colombo Runxiang Yang The BMJ Wei Zheng Wenfeng Fang Wenxiu Yao Wu Zhuang Xia Song Xiangjiao Meng Xiaoping Jin Xingya Li Yina Diao Yongzhong Luo Yun Fan Zhiye Zhang
Special Coverage
Blog
Jul 3, 2025, 09:58
Society for Integrative Oncology - A Practical and Patient-friendly Guide to Integrative Oncology
Opinion
Jul 3, 2025, 09:50
Childhood Cancer International - Now is the Time to Make Your Voice Heard
Blog
Jul 3, 2025, 09:48
Kilele Challenge at Kereita Forest Gave Cancer Warriors and Caregivers Something They Rarely Get - Kilele Health
Blog
Jul 3, 2025, 09:41
Silvia Romeo: Accelerating Progress Toward's EU's Goal of Eliminating HPV Cancers
Science
Jul 3, 2025, 09:41
Elvina Almuradova: Our Recent Meta-analysis on the Impact of Omitting The 5-FU Bolus From Chemotherapy Regimens
Blog
Jul 3, 2025, 09:04
Pat Garcia-Gonzalez: Acting with Humanity - Donating My Birthday - Supporting Cancer Patients in Nepal
Insight
Jul 3, 2025, 09:04
Diego A. Díaz García Highlighted 2024 Review Article on Advances in Liquid Biopsy
Blog
Jul 3, 2025, 08:53
Emma Ter-Azaryan: This is Where I'm Meant To Be
Blog
Jul 3, 2025, 08:48
Supriya Peshin: How Bone Metastases Impact Outcomes in Young Patients with Colorectal Cancer
Blog
Jul 3, 2025, 08:39
Corinne Hall: ESO College Members Our Voices Contest is Back!
Blog
Jul 3, 2025, 08:27
CancerWorld #105 (July 2025) is Here
Blog
Jul 3, 2025, 08:20
SITC - JITC Has Reached an Impact Factor of 10.6 and a CiteScore of 17.8 in 2024!